Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 122 participants.
Also called NCT05730413
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 122 participants
- Sponsor
- Registry
-
NCT05730413
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Unknown status
Technical summary
Registry record NCT05730413. Randomized; no masking; primary purpose prevention. Start 2021-08-25 (actual); primary completion 2023-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery
- Condition
- Coronary Artery Bypass Grafting
- Condition
- Postoperative Atrial Fibrillation
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Bisoprolol
- Intervention (Drug)
- Bisoprolol
- Lead sponsor
- Cairo University
Record details
- Record id
cardio:ct-nct05730413- Content hash
913aaa2100da9fa24eab348248be6a9ae71dfec4ad7f05fba2a69ea5b6b64d03